Is a Surprise Coming for Sanofi (SNY) This Earnings Season?
Sanofi (SNY) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season....…
45,900€
0,66%
Echtzeit-Aktienkurs Sanofi S.A. (Sp. ADRs)
Bid:
Ask:
Nachrichten zur Sanofi S.A. (Sp. ADRs) Aktie
Sanofi 1Q Sales Expected to Increase -- Earnings Preview
Sanofi 1Q Sales Expected to Increase -- Earnings Preview...…
Provention Bio gains after HSR waiting period for Sanofi deal expired
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Eli Lily and Company, Merck & Co, AstraZeneca PLC, Sanofi and ...
Um den gesamten Artikel unter news.google.com zu lesen, klicken Sie bitte auf die Überschrift...…
Form 6-K Sanofi For: Apr 24
Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…
Sanofi Launches Hepatitis A Vaccine In U.K For Use In Children Aged 12 Months To 15 Yrs
PARIS (dpa-AFX) - Sanofi (SNY) announced launch of Avaxim Junior in the UK for active immunisation against infection caused by…
Sanofi (SNY) is a Great Momentum Stock: Should You Buy?
Does Sanofi (SNY) have what it takes to be a top stock pick for momentum investors? Lets find out....…
Eli Lilly, Novo Nordisk and Sanofi CEOs to testify before Senate on lowering insulin prices
Eli Lilly, Novo Nordisk and Sanofi control 90% of the insulin market in the U.S, where a quarter of all…
Sanofi Overweight
NEW YORK (dpa-AFX Analyser) - Die US-Bank JPMorgan hat die Einstufung für Sanofi vor Quartalszahlen auf "Overweight" mit einem Kursziel…
Sanofi (SNY) Stock Moves -0.45%: What You Should Know
In the latest trading session, Sanofi (SNY) closed at $55.47, marking a -0.45% move from the previous day....…
Zacks.com featured highlights include Unum, Graphic Packaging Holding, AutoNation and Sanofi
Unum, Graphic Packaging Holding, AutoNation and Sanofi are part of the Zacks Screen of the Week article....…
Sanofi Hold
FRANKFURT (dpa-AFX Analyser) - Deutsche Bank Research hat das Kursziel für Sanofi vor Quartalszahlen des Pharmakonzerns von 85 auf…
Sanofi: Information concerning the total number of voting rights and shares - March 2023
Information concerning the total number of voting rights and shares, provided pursuant to article L. 233-8 II of the Code…
Zacks.com featured highlights include Unum Group, Sanofi, KB Home, PVH and Telefonica Brasil
Unum Group, Sanofi, KB Home, PVH and Telefonica Brasil are part of the Zacks Screen of the Week article....…
Sanofi Buy
NEW YORK (dpa-AFX Analyser) - Das Analysehaus Jefferies hat die Einstufung für Sanofi vor den am 27. April erwarteten Zahlen…
3 Reasons Growth Investors Will Love Sanofi (SNY)
Sanofi (SNY) possesses solid growth attributes, which could help it handily outperform the market....…
Supreme Court turns down Sanofi bid to revive EpiPen lawsuit against Viatris
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Sanofi Overweight
NEW YORK (dpa-AFX Analyser) - Die US-Bank JPMorgan hat die Einstufung für Sanofi vor Zahlen zum ersten Quartal auf "Overweight"…
Sanofi: Neues Kursziel
New York (www.aktiencheck.de) - Rating-Update:
Die Analysten von Guggenheim Securities stufen die Aktie des französischen Pharmakonzerns Sanofi S.A. (ISIN: FR0000120578, WKN:…
AstraZeneca (AZN), Sanofi Simply RSV Antibody Agreement Terms
AstraZeneca (AZN) and Sanofi (SNY) revise the contractual terms of the agreement for Beyfortus. Sanofi will have full commercial control…
Form 6-K Sanofi For: Apr 11
Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…
TOP NEWS: Sanofi wins US drug control from AstraZeneca in Sobi deal
Um den gesamten Artikel unter morningstar.co.uk zu lesen, klicken Sie bitte auf die Überschrift...…
Sanofi to get commercial control of RSV therapy nirsevimab in US, AstraZeneca to record $0.7B gain
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Sanofi bekommt Astrazeneca-Anteil an RSV-Lizenz in USA
Von Cecilia Butini BARCELONA (Dow Jones)--Sanofi bekommt die volle kommerzielle Kontrolle über eine Antikörperbehandlung gegen das Respiratorische Synzytialvirus (RSV)…
Sanofi Gets Full Commercial Control on Virus Medication From AstraZeneca in U.S.
Sanofi Gets Full Commercial Control on Virus Medication From AstraZeneca in U.S....…
Press Release: Nirsevimab: Sanofi, AstraZeneca and Sobi simplify contractual agreements
Um den gesamten Artikel unter globenewswire.com zu lesen, klicken Sie bitte auf die Überschrift...…
Update to arrangements with Sobi and Sanofi
11 April 2023 07:00 BST
Update to contractual arrangements between AstraZeneca, Swedish Orphan Biovitrum AB and Sanofi
AstraZeneca, Swedish Orphan Biovitrum AB…
Sanofi Refiles Premerger Notification And Report Form On Provention Bio Acquisition
PARIS (dpa-AFX) - Sanofi (SNYNF, SNY), a French pharma and healthcare firm, said that it has withdrawn and refiled its…
Sanofi withdraws and refiles pre-merger notification, report form to acquire Provention Bio
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Press Release: Sanofi announces withdrawal and refiling of Premerger Notification and Report Form under the HSR Act and extension of tender offer to acquire Provention Bio, Inc.
Sanofi announces withdrawal and refiling of Premerger Notification and Report Form under the HSR Act and extension of tender offer…
Sobi to streamline nirsevimab contractual arrangements
Nirsevimab economics simplified through a new royalty agreement with Sanofi and the termination of the participation agreement with AstraZeneca
Alignment will…
Sanofi, BARDA break ground on new flu vaccine facility at Pennsylvania site
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Sanofi (SNY) Stock Sinks As Market Gains: What You Should Know
In the latest trading session, Sanofi (SNY) closed at $54.18, marking a -0.44% move from the previous day....…
Sanofi plans to spin-off consumer business in India - report
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Sanofi looks to spin off consumer business in India - ET
...(Reuters) - French drugmaker Sanofi has started a process to turn......…
Sanofi Neutral
ZÜRICH (dpa-AFX Analyser) - Die Schweizer Großbank UBS hat das Kursziel für Sanofi von 93 auf 100 Euro angehoben und…
Is This Pharma Duo on the Brink of Another Billion-Dollar Opportunity?
Sanofi and Regenerons top-selling drug could soon be approved to treat yet another disease....…
Sanofi: Kursziel erhöht
New York (www.aktiencheck.de) - Rating-Update:
Jasper Hellweg, Analyst von Argus Research, stuft die Aktie des französischen Pharmakonzerns Sanofi S.A. (ISIN: FR0000120578,…
Sanofi (SNY) Outpaces Stock Market Gains: What You Should Know
Sanofi (SNY) closed at $53.22 in the latest trading session, marking a +1.16% move from the prior day....…
Amgen-Sanofi patent case divides makers of antibody drugs
...By Patrick Wingrove
(Reuters) - Amgen Incs battle with Sanofi......…
Supreme Court hears arguments in Amgen Repatha patent case against Sanofi
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
QIX Dividenden Europa: Starke "Dupixent"-Studiendaten treiben Sanofi-Aktie über 6 % ins Plus
Nach dem gestrigen geldpolitischen Straffungskurs der US-Notenbank zeigt sich der QIX Dividenden Europa Index am Donnerstag kaum verändert bei 12.290…
The Zacks Analyst Blog Highlights Sanofi, Regeneron, AbbVie, Roche and Eli Lilly
Sanofi, Regeneron, AbbVie, Roche and Eli Lilly are included in this Analyst Blog....…
Sanofi Overweight
LONDON (dpa-AFX Analyser) - Die britische Investmentbank Barclays hat Sanofi von "Equal Weight" auf "Overweight" hochgestuft und das Kursziel von…
Pharmaindustrie: Sanofi-Blockbuster Dupixent punktet mit Studienerfolg bei Raucherlunge
Das Mittel des Pharmakonzerns erreichte in der klinischen Studie alle Zielvorgaben. Dadurch kann das Unternehmen auf zusätzliche Milliardeneinnahmen hoffen....…
Regeneron, Sanofi Look for Billions From COPD Drug
The companies said Dupixent showed positive results in a late-stage study of current or former smokers with the killer disease....…
Could This Label Expansion Be a Growth Catalyst for Sanofi Stock?
Sanofi and Regenerons mega-blockbuster drug could soon be approved in the U.S. for yet another indication....…
Is Sanofi Stock a Buy Now?
The pharma giant has outperformed the broader market over the past 12 months....…
Regeneron Pharmaceuticals Analysts React To Drug Trial Results: Why Whales Are Diving In
Regeneron Pharmaceuticals Inc (NASDAQ: REGN) announced the Phase 3 trial of Dupixent (dupilumab), developed with Sanofi (NASDAQ: SNY), for uncontrolled chronic…
Sanofi (SNY) Moves 6.0% Higher: Will This Strength Last?
Sanofi (SNY) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might…